Free Trial

Beyond Air Q1 2024 Earnings Report

Beyond Air logo
$0.40 -0.01 (-3.12%)
(As of 12/20/2024 05:40 PM ET)

Beyond Air EPS Results

Actual EPS
-$0.45
Consensus EPS
-$0.46
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Beyond Air Revenue Results

Actual Revenue
$0.06 million
Expected Revenue
$0.20 million
Beat/Miss
Missed by -$140.00 thousand
YoY Revenue Growth
N/A

Beyond Air Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Beyond Air Earnings Headlines

Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!
Beyond Air receives CE Mark for LungFit PH System
See More Beyond Air Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Beyond Air? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Beyond Air and other key companies, straight to your email.

About Beyond Air

Beyond Air (NASDAQ:XAIR) operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

View Beyond Air Profile

More Earnings Resources from MarketBeat

Upcoming Earnings